| Structure |
Chemical Name |
CAS |
MF |
 |
Tofacitinib Impurity 110 |
|
|
![(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole](/CAS/20210111/GIF/65576-39-8.gif) |
(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
65576-39-8 |
C17H17NO |
 |
Bisoprolol-d5 |
1189881-87-5 |
C18H31NO4 |
 |
Pregabalin Impurity 32 |
|
|
 |
Dapoxetine Impurity 11 |
151649-29-5 |
C19H16O |
 |
Irbesartan Impurity 6 |
|
C25H28N6O |
 |
(6-BroMo-2-ethyl-3-benzofuranyl)(3,5-dibroMo-4-hydroxyphenyl)Methanone |
1402819-05-9 |
C17H11Br3O3 |
 |
Tolterodine Impurity 1 |
88407-28-7 |
C22H31NO |
![ethyl N-[(2,5-dichlorophenyl)carbonyl]glycinate](/CAS/20180601/GIF/328283-61-0.gif) |
ethyl N-[(2,5-dichlorophenyl)carbonyl]glycinate |
328283-61-0 |
C11H11Cl2NO3 |
 |
Sorafenib related compound 12 |
284461-74-1 |
C20H14ClF3N4O3 |
 |
trans-Ibuprofen Impurity G |
|
C13H18O2 |
 |
Trelagliptin Impurity X |
1938080-44-4 |
C18H22FN5O3 |
 |
Axitinib Sulfonyl |
1348536-59-3 |
C22H18N4O3S |
 |
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
 |
3,3'-diMethyl-1,1'-diphenyl-1H,1'H-4,4'-bipyrazole-5,5'-diol |
177415-76-8 |
C20H18N4O2 |
 |
Olaparib Impurity Q |
|
|
 |
Low concentration active component standard gas |
|
|
 |
1,3-ジメチル-5,5-ジ(2-プロペニル)ピリミジン-2,4,6(1H,3H,5H)-トリオン |
722-97-4 |
C12H16N2O3 |
 |
Intedanib Impurity |
2243396-74-7 |
C31H32N6O6 |
 |
5-Fluoro ent-LaMivudine Acid D-Menthol Ester |
764659-79-2 |
C18H26FN3O4S |
 |
N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-78-2 |
C19H24N4O3 |
 |
Dextrorotation lansoprazole Impurity K |
|
|
 |
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine |
641571-16-6 |
C11H10F3N3 |
![2,4(1H,3H)-Pyrimidinedione, 3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-](/CAS/20200331/GIF/2354391-45-8.gif) |
2,4(1H,3H)-Pyrimidinedione, 3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl- |
2354391-45-8 |
C13H10F4N2O2 |
 |
Cabozantinib impurity 29 |
|
|
 |
Ninhydrine, ozone friendly ready to use spray for TLC chromatography |
32-70-2 |
C9H4O3.H2O
|
 |
4-(4-chlorophenyl)-5-methyl-3-phenylisoxazole |
1448355-87-0 |
C16H12ClNO |
 |
Flucloxacillin impurity C |
|
|
 |
Mirabegron Impurity 21 |
|
|
 |
Ropivacaine Impurity 32 |
|
|
 |
Carfilzomib Impurity 1 |
|
|
 |
Lansoprazole IMpurity I |
|
|
![D-Streptamine, O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(1→4)]-N1-[(2R)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-](/CAS/20211123/GIF/50896-99-6.gif) |
D-Streptamine, O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(1→4)]-N1-[(2R)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy- |
50896-99-6 |
C22H43N5O13 |
 |
NSC 609249 |
51012-67-0 |
C12H20ClNO2 |
 |
4-(5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl)picolinamide |
1992028-94-0 |
C13H10N6O |
![(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid](/CAS/20180703/GIF/1026952-91-9.gif) |
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
 |
Flucloxacillin Sodium Impurity A |
68728-50-7 |
C19H20ClFN3NaO6S |
 |
Parecoxib Sodium Imp.E |
|
|
 |
EsCitalopram EP Impurity I |
1370643-22-3 |
C20H21FN2O |
 |
(2R,3R,4R,5S)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-fluoro-4-Methyltetrahydrofuran-3-yl benzoate |
874638-94-5 |
C31H26FN3O7 |
 |
Carfilzomib Impurity 5 |
|
|
 |
Ruxolitinib Impurity |
|
|
 |
Palbociclib impurity LMAP |
|
|
 |
Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate |
1206875-41-3 |
C15H22N2O2 |
 |
エタンスルホン酸エチル |
1912-30-7 |
C4H10O3S |
 |
Carfilzomib Impurity 6 |
|
|
 |
Solifenacin Related CoMpound 5 |
|
|
 |
Dapoxetine Impurity D |
|
|
 |
Empagliflozin Impurity 23 |
|
|
 |
Olaparib Impurity C |
|
|
![(R)-3-amino-4-phenyl-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one](/CAS/20200331/GIF/CB54744851.gif) |
(R)-3-amino-4-phenyl-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one |
2749805-70-5 |
C16H18F3N5O |
![9-[(Z)-1-プロペニル]-9H-プリン-6-アミン](/CAS/20180703/GIF/1464851-21-5.gif) |
9-[(Z)-1-プロペニル]-9H-プリン-6-アミン |
1464851-21-5 |
C8H9N5 |
 |
Ropivacaine-iPr |
175888-75-2 |
C17H26N2O |
 |
3,5-ジヨード-4-(3,5-ジヨード-4-ヒドロキシフェノキシ)ベンゼン酢酸 |
67-30-1 |
C14H8I4O4 |
 |
Tirofiban Impurity 3 |
1346918-32-8 |
C13H19NO5S |
 |
Isavuconazole Impurity 4 |
|
|
 |
Linagliptin Impurity D |
666816-91-7 |
C20H28N6O4 |
 |
1,2-Bis(piperazin-1-yl)benzene |
1446750-99-7 |
C14H22N4 |
 |
Pitavastatin Impurity 39 |
|
|
 |
Captopril IMpurity H |
205521-07-9 |
C15H23NO5S2 |
 |
ブロバクタムS,S-ジオキシド |
75527-87-6 |
C8H10BrNO5S |
 |
Iohexol related Compound I |
|
|
 |
1-HEXADECANOYL-2-(P-NITROPHENOXYSUCCINOYL)-SN-GLYCERYL-3-PHOSPHORYLCHOLINE |
170569-87-6 |
C16H12F3N3O2S |
 |
Meropenem impurity diastereomer 2 |
96035-15-3 |
C15H19N3O5S |
 |
Oxcarbazepine Impurity3 |
|
|
 |
Tofacitinib Impurity 87 |
|
|
 |
Cefamandole Impurity A |
1947364-12-6 |
C17H16N2O6S |
 |
Ticagrelor Impurity 122 |
|
|
 |
Doxofylline Impurity 1 |
1429636-74-7 |
C10H16N4O3 |
 |
DESULFO AZTREONAM TRIFLUOROACETIC ACID SALT (CONTAINS 〜20% UNKNOWN INORGANIC SALTS) |
102579-59-9 |
C13H17N5O5S |
 |
Linagliptin Impurity 30 |
2074688-81-4 |
C33H32N8O5 |
 |
Bumetanide Impurity 25 |
|
|
 |
tert-butyl (4-(4-(3-chloroazetidin-1-yl)piperidin-1-yl)-2-methoxy-5- nitrophenyl)carbamate |
|
|
 |
Trelagliptin Impurity 42 |
|
|
![[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine](/CAS/GIF/170729-79-0.gif) |
[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine |
170729-79-0 |
C20H18F7NO2 |
 |
Alogliptin Impurity 27 |
|
|
 |
6-ヒドロキシケンフェロール 3-ルチノシド-6-グルコシド |
145134-63-0 |
C33H40O21 |
 |
1-(1-BENZOTHIOPHEN-7-YL)PIPERAZINE |
105685-06-1 |
C12H14N2S |
 |
Tenofovir Impurity 54 |
|
|
![Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:)](/CAS/20211123/GIF/571189-66-7.gif) |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:) |
571189-66-7 |
C22H28ClN7O |
![安息香酸3-[7-シアノ-5-[(2R)-2-[[2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチル]アミノ]プロピル]インドリン-1-イル]プロピル](/CAS/GIF/885340-11-4.gif) |
安息香酸3-[7-シアノ-5-[(2R)-2-[[2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチル]アミノ]プロピル]インドリン-1-イル]プロピル |
885340-11-4 |
C32H34F3N3O4 |
 |
Everolimus Impurity E |
|
|
 |
Caspofungin IMpurity A |
1202167-57-4 |
C51H86N10O15 |
 |
cefaclor iMpurity G |
67308-21-8 |
C16H17N3O4S |
 |
RP 48497 (Eszopiclone Impurity C) |
148891-53-6 |
C11H7ClN4O |
 |
N-nitroso-levomethoate 1 |
|
|
 |
Canagliflozin Impurity 13 |
|
|
 |
EsoMeprazole iMpurity |
1424857-86-2 |
C11H15NO3 |
 |
N1-benzyl-N1,4-dimethyl-N3-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C24H23N5 |
 |
Nicergoline Impurity G |
|
|
 |
Digoxin Impurity 2 |
|
|
 |
Clopidogrel Impurity 13 |
2173294-69-2 |
C16H16ClNO5S2 |
 |
Adefovir Impurity 1 |
|
|
 |
N-(2-((4-amino-6-(3-(4-cyclopropyl-2-fluorobenzamido)-5-fluoro-2-methylphenyl)pyrimidin-5-yl)oxy)ethyl)-N-methyloxirane-2-carboxamide |
1787294-16-9 |
C27H27F2N5O4 |
 |
NSC4751 |
5393-61-3 |
C10H10N2O2 |
 |
Mixed gas of propane, carbon monoxide and carbon dioxide |
|
|
 |
Dextrorotation lansoprazole Impurity M |
|
|
 |
1,4'-Bipiperidine, 1'-(phenylmethyl)- |
116269-53-5 |
C17H26N2 |
 |
Bosutinib Impurity 2 (N-Desmethyl Bosutinib) |
380843-81-2 |
C25H27Cl2N5O3 |
 |
Carfilzomib Impurity D |
|
|